(Q33182519)

23 July 2017

title

Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families (English)

1 reference

23 July 2017

1 reference

9

Devilee P

1 reference

23 July 2017

10

Seynaeve C

1 reference

23 July 2017

Hanne Meijers-Heijboer

14

object named as

Meijers-Heijboer H

1 reference

23 July 2017

Ans M W van den Ouweland

2

object named as

van den Ouweland AM

1 reference

23 July 2017

Verhoog LC

1

1 reference

23 July 2017

Berns E

3

1 reference

23 July 2017

van Veghel-Plandsoen MM

4

1 reference

23 July 2017

van Staveren IL

5

1 reference

23 July 2017

Wagner A

6

1 reference

23 July 2017

Bartels CC

7

1 reference

23 July 2017

Tilanus-Linthorst MM

8

1 reference

23 July 2017

Halley DJ

11

1 reference

23 July 2017

Niermeijer MF

12

1 reference

23 July 2017

Klijn JG

13

1 reference

23 July 2017

publication date

1 November 2001

1 reference

European Journal of Cancer

23 July 2017

published in

1 reference

23 July 2017

volume

37

1 reference

23 July 2017

issue

16

1 reference

23 July 2017

page(s)

2082-2090

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Identification of a founder BRCA2 mutation in Sardinia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Rapid detection of BRCA1 mutations by the protein truncation test

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

The gene for triphalangeal thumb maps to the subtelomeric region of chromosome 7q.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900244-1

7 January 2021

10.1016/S0959-8049(01)00244-1

Identifiers

DOI

1 reference

23 July 2017

1 reference